Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors

Cysteinyl-tRNA Deacylation Can Be Uncoupled from Protein Synthesis

(2012) Alexandre David et al.   PLoS One

The Proteasome in Terminal Plasma Cell Differentiation

(2012) Simone Cenci   SEMINARS IN HEMATOLOGY

RNA Binding Targets Aminoacyl-tRNA Synthetases to Translating Ribosomes

(2011) Alexandre David et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Amyloidosis: Pathogenesis and New Therapeutic Options

(2011) Giampaolo Merlini et al.   JOURNAL OF CLINICAL ONCOLOGY

Proteostenosis and plasma cell pathophysiology

(2010) Simone Cenci et al.   CURRENT OPINION IN CELL BIOLOGY

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

(2010) Maria-Victoria Mateos et al.   JOURNAL OF CLINICAL ONCOLOGY

The Early Marginal Zone B Cell-Initiated T-Independent Type 2 Response Resists the Proteasome Inhibitor Bortezomib

(2010) V. R. Lang et al.   JOURNAL OF IMMUNOLOGY

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

(2009) G. Bianchi et al.   BLOOD

Protein Homeostasis and Aging: Taking Care of Proteins From the Cradle to the Grave

(2009) R. I. Morimoto et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Innate immune and chemically triggered oxidative stress modifies translational fidelity

(2009) Nir Netzer et al.   NATURE

Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production

(2008) D. K. Perry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Dampening Ab responses using proteasome inhibitors followingin vivo B cell activation

(2008) Paolo Cascio et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging

(2008) R. I. Morimoto   GENES & DEVELOPMENT

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lentiviral Vector Gene Transfer Is Limited by the Proteasome at Postentry Steps in Various Types of Stem Cells

(2008) Francesca Romana Santoni de Sio et al.   STEM CELLS